Indicators

Markets:

News

Latest News about ALNY

Recent news which mentions ALNY

...

4 5 6 7 8 9 10 11 Next >

Why Is Alnylam (ALNY) Stock Up 50% Today?

August 03, 2022

Alnylam Shares Shoot Higher Following Positive Clinical Results From Late-Stage ATTR Amyloidosis Therapeutics

August 03, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

Why Alnylam Pharmaceuticals Stock Is Vaulting Higher Today

August 03, 2022

Why Alnylam Pharma Shares Are Trading Higher During Premarket Session

August 03, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

August 03, 2022

Alnylam's Strategy Is Getting Bigger. Time to Buy?

July 30, 2022

10 Health Care Stocks Whale Activity In Today's Session

July 28, 2022

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

July 28, 2022

Alnylam Pharmaceuticals: Q2 Earnings Insights

July 28, 2022

Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform

July 25, 2022

Expert Ratings for Alnylam Pharmaceuticals

July 15, 2022

Alnylam Hits Moderna With Another Patent Infringement Suit-Related To COVID-19 Vaccine

July 15, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

July 13, 2022

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

July 01, 2022

Where Alnylam Pharmaceuticals Stands With Analysts

June 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

June 27, 2022

Seven reasons the beleaguered biotech sector is now a ‘buy’

June 17, 2022

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate

June 14, 2022

Alnylam's Stock Gains Following FDA Nod For hATTR Amyloidosis Candidate

June 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

June 07, 2022

Analyst Ratings for Alnylam Pharmaceuticals

June 07, 2022

Alnylam's Lumasiran Shows Clinical Benefit In Rare Kidney Disease

May 24, 2022

Why HC Wainwright Is Bullish On This Stock's Hepatitis-B Pipeline

May 02, 2022

10 Biggest Price Target Changes For Monday

May 02, 2022

Expert Ratings for Alnylam Pharmaceuticals

April 29, 2022

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

April 28, 2022

What To Know About Morgan Stanley's Downgrade of Alnylam Pharmaceuticals

April 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

April 25, 2022

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

April 24, 2022

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.